Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 228 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page


    Advanced search

    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded185    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


LETTER TO EDITOR Table of Contents   
Year : 2009  |  Volume : 51  |  Issue : 4  |  Page : 329-330
Toluene associated schizophrenia-like psychosis

Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore - 560 029, India

Click here for correspondence address and email

Date of Web Publication10-Dec-2009

How to cite this article:
Rao NP, Gupta A, Sreejayan K, Chand PK, Benegal V, Murthy P. Toluene associated schizophrenia-like psychosis. Indian J Psychiatry 2009;51:329-30

How to cite this URL:
Rao NP, Gupta A, Sreejayan K, Chand PK, Benegal V, Murthy P. Toluene associated schizophrenia-like psychosis. Indian J Psychiatry [serial online] 2009 [cited 2021 Oct 21];51:329-30. Available from:


Inhalants are commonly abused drugs in adolescent population though often unrecognized. On long-term use they can result in serious sequels like optic atrophy and psychosis, resembling schizophrenia, and thus need awareness among physicians and psychiatrists. While there have been case reports on inhalant abuse in India, [1] there has been no report describing psychosis following toluene use. In this report we describe a patient presenting with psychosis following toluene use and improvement of psychosis with abstinence.

Mr. A., a 23-year-old man, was brought to the hospital in 2006, with a history of huffing correction fluid (eraz-ex), containing toluene since eight years. He was using around 300 ml per day. He had craving, tolerance, and continued using it despite the harm. Since three years the family reported behavioral changes in him, in the form of suspiciousness that neighbors were trying to harm him, making gestures with sexual connotations, and hearing voices commenting on his actions. He would hoard garbage and dead crows. These behaviors were persistent and worsened with time, without features suggestive of altered sensorium. He was never abstinent of the inhalant. He also complained of blurred vision since two years. There was no past or family history of any psychotic episode. He did not report abuse of any other drug except nicotine.

On examination he had delusions of persecution, reference, a bizarre delusion that a five-headed snake was inside him, and auditory hallucinations. He scored 50 on the Brief Psychiatric Rating Scale (BPRS) on the day of admission. Physical examination showed hyperemia of fundus and blurred vision in both eyes. His breath smelt of toluene. There were no other neurological abnormalities on physical examination. A drug screen was negative for cannabis, opioid, and benzodiazepines. A CT scan of the brain was normal. Mr. A was diagnosed as having volatile solvent dependence, solvent-induced, schizophrenia-like psychotic disorder (ICD-10). The ophthalmologist's opinion was taken and he was diagnosed with toxic maculopathy.

He was treated with diazepam for sleep disturbance and agitation. He was abstinent of all substances during hospital stay. Within two weeks all his psychotic symptoms subsided without any antipsychotic. He scored 33 on the tenth day and 28 on the fifteenth day on BPRS. However, his visual impairment remained unchanged.

The index patient presented with chronic solvent abuse and persistent bizarre delusions and hallucinations and the symptoms decreased within 15 days following abstinence from toluene, without antipsychotic medication. Hence we attribute the symptoms to chronic toluene use. Optic neuropathy has been described with toluene abuse, [2] as seen in the index patient. There has been a report of chronic industrial exposure to toluene resulting in psychotic symptoms. [3] Treatment of inhalant-induced psychotic disorder has primarily involved the use of antipsychotics and anticonvulsants such as carbamazepine and haloperidol. [4] However, few workers report that central nervous system damage is repaired with abstinence and time alone. [5] In the index patient, the psychotic symptoms subsided with abstinence and supportive treatment, without requiring treatment with antipsychotics supporting the view mentioned earlier. However, more studies need to be conducted, to confirm the association of solvents and psychosis.

   References Top

1.Basu D, Jhirwal OP, Singh J, Kumar S, Mattoo SK. Inhalant abuse by adolescents: A new challenge for Indian physicians. Indian J Med Sci 2004;58:245-9.  Back to cited text no. 1  [PUBMED]  Medknow Journal  
2.Keane JR. Toluene optic neuropathy. Ann Neurol 1978;4:390.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Goldbloom D, Chouinard G. Schizophreniform psychosis associated with chronic industrial toluene exposure: Case report. J Clin Psychiatry 1985;46:350-1.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Hernandez-Avila CA, Ortega-Soto HA, Jasso A, Hasfura-Buenaga CA, Kranzler HR. Treatment of inhalant-induced psychotic disorder with carbamazepine versus haloperidol. Psychiatr Serv 1998;49:812-5.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Westermeyer J. The psychiatrist and solvent-inhalant abuse: Recognition, assessment, and treatment. Am J Psychiatry 1987;144:903-7.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  

Correspondence Address:
Naren P Rao
Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore - 560 029
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5545.58307

Rights and Permissions

This article has been cited by
1 Not lesser but Greater fractional anisotropy in adolescents with alcohol use disorders
Valerie A. Cardenas,David Greenstein,Jean-Paul Fouche,Helen Ferrett,Natalie Cuzen,Dan J. Stein,George Fein
NeuroImage: Clinical. 2013; 2: 804
[Pubmed] | [DOI]
2 Exposure and susceptibility: Schizophrenia in a young man following prolonged high exposures to organic solvents
Stein, Y., Finkelstein, Y., Levy-Nativ, O., Bonne, O., Aschner, M., Richter, E.D.
NeuroToxicology. 2010; 31(5): 603-607